Literature DB >> 2585485

Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme.

J A Kelly1, J R Knox, H Zhao, J M Frère, J M Ghaysen.   

Abstract

X-ray crystallography has been used to examine the binding of three members of the beta-lactam family of antibiotics to the D-alanyl-D-alanine peptidase from Streptomyces R61, a target of penicillins. Cephalosporin C, the monobactam analog of penicillin G and (2,3)-alpha-methylene benzylpenicillin have been mapped at 2.3 A resolution in the form of acyl-enzyme complexes bound to serine 62. On the basis of the positions of these inhibitors, the binding of a tripeptide substrate for the enzyme, L-lysyl-D-alanyl-D-alanine, has been modeled in the active site. The binding of both inhibitors and substrate is facilitated by hydrogen-bonding interactions with a conserved beta-strand (297-303), which is antiparallel to the beta-lactam's acylamide linkage or the substrate's peptide bond. The active site is similar to that in beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585485     DOI: 10.1016/0022-2836(89)90277-5

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  30 in total

1.  Importance of the two tryptophan residues in the Streptomyces R61 exocellular DD-peptidase.

Authors:  C Bourguignon-Bellefroid; J M Wilkin; B Joris; R T Aplin; C Houssier; F G Prendergast; J Van Beeumen; J M Ghuysen; J M Frère
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity.

Authors:  George Nicola; Joshua Tomberg; R F Pratt; Robert A Nicholas; Christopher Davies
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

Review 3.  Novel biochemistry: post-translational protein splicing and other lessons from the school of antigen processing.

Authors:  Ken-ichi Hanada; James C Yang
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

4.  Specificity inversion of Ochrobactrum anthropi D-aminopeptidase to a D,D-carboxypeptidase with new penicillin binding activity by directed mutagenesis.

Authors:  Michaël Delmarcelle; Marie-Caroline Boursoit; Patrice Filée; Stéphane Lucius Baurin; Jean-Marie Frère; Bernard Joris
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

5.  The mutation Lys234His yields a class A beta-lactamase with a novel pH-dependence.

Authors:  J Brannigan; A Matagne; F Jacob; C Damblon; B Joris; D Klein; B G Spratt; J M Frère
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

6.  Different modes of vancomycin and D-alanyl-D-alanine peptidase binding to cell wall peptide and a possible role for the vancomycin resistance protein.

Authors:  J R Knox; R F Pratt
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

7.  Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.

Authors:  H Christensen; M T Martin; S G Waley
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

8.  On the electrostatic and steric similarity of lactam compounds and the natural substrate for bacterial cell-wall biosynthesis.

Authors:  J Frau; S L Price
Journal:  J Comput Aided Mol Des       Date:  1996-04       Impact factor: 3.686

9.  A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus.

Authors:  Nabil M Abraham; Lei Liu; Brandon L Jutras; Kristen Murfin; Ali Acar; Timur O Yarovinsky; Erica Sutton; Martin Heisig; Christine Jacobs-Wagner; Erol Fikrig
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

10.  Importance of the His-298 residue in the catalytic mechanism of the Streptomyces R61 extracellular DD-peptidase.

Authors:  A M Hadonou; M Jamin; M Adam; B Joris; J Dusart; J M Ghuysen; J M Frère
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.